Project documents | Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799] | Guidance | NICE

Documents

A list of downloadable documents created during development.

Appeal

Appeal
Solving Kids' Cancer : Appeal letter ^{PDF 463 KB} 30 September 2016
Solving Kids' Cancer : Scrutiny letter ^{PDF 165 KB} 30 September 2016
Solving Kids' Cancer : Response to scrutiny letter ^{PDF 449 KB} 30 September 2016
Solving Kids' Cancer : Final scrutiny letter ^{PDF 153 KB} 30 September 2016
Solving Kids' Cancer : Written submission ^{PDF 964 KB} 03 October 2016
Solving Kids' Cancer : Written submission ^{PDF 236 KB} 03 October 2016
Solving Kids' Cancer : Written submission ^{PDF 210 KB} 03 October 2016
Appeal decision ^{PDF 306 KB} 29 November 2016

Final appraisal determination: 2

Final appraisal determination: 2
Final appraisal determination document ^{PDF 398 KB} 15 July 2016
Committee papers ^{PDF 2.96 MB} 15 July 2016

Draft guidance

Draft guidance
Committee papers ^{PDF 7.59 MB} 05 November 2015
Appraisal consultation document ^{PDF 412 KB} 05 November 2015

Invitation to participate

Final matrix ^{PDF 128 KB} 27 October 2015
Final scope ^{PDF 35 KB} 13 February 2017
Final matrix ^{PDF 99 KB} 13 February 2017
Draft scope and provisional matrix comments table (post-referral) ^{PDF 168 KB} 13 February 2017
Equality impact assessment (Scoping) ^{PDF 174 KB} 13 February 2017

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014 ^{PDF 105 KB} 05 May 2015

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014 ^{PDF 99 KB} 05 May 2015